Pfizer will begin testing a version of its COVID-19 vaccine that doesn’t require cold storage. A freeze-dried vaccine would be easier to distribute throughout rural parts of the U.S. and to low-income countries. (The Wall Street Journal)

Vaccine hesitancy has dropped among all Americans, according to a new survey. More than half of Black adults in the U.S. said they were vaccinated or planned to be, an increase from 14% in February. (Kaiser Health News)

As part of the Biden administration’s plan to boost vaccine confidence, a new volunteer network will aim to raise awareness in a range of communities. The COVID-19 Community Corps will spearhead on-the-ground programs to battle vaccine hesitancy. (POLITICO)

Most U.S. universities failed to commit to ensuring access and affordability of drugs they develop, according to a new analysis. Only 12% of universities in the report committed to prioritizing generic medicine production for low-income countries. (STAT)

Omega Therapeutics closed $126 million in Series B funding to test its lead epigenomic controller candidate in humans. The company hopes to test the possibility of adjusting gene expression in a hyper-targeted way. (Endpoints News)